Statement Of Income And Retained Earnings

JCR Pharmaceuticals Co.,Ltd. - Filing #7360123

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
5,095,000,000 JPY
4,975,000,000 JPY
19,933,000,000 JPY
20,137,000,000 JPY
Non-operating income
Non-operating income
557,000,000 JPY
541,000,000 JPY
656,000,000 JPY
641,000,000 JPY
Non-operating expenses
Non-operating expenses
368,000,000 JPY
99,000,000 JPY
77,000,000 JPY
353,000,000 JPY
Ordinary profit (loss)
5,284,000,000 JPY
5,418,000,000 JPY
20,512,000,000 JPY
20,425,000,000 JPY
Extraordinary income
Extraordinary income
10,000,000 JPY
10,000,000 JPY
0 JPY
0 JPY
Extraordinary losses
Extraordinary losses
16,000,000 JPY
16,000,000 JPY
1,108,000,000 JPY
1,108,000,000 JPY
Profit (loss) before income taxes
5,278,000,000 JPY
5,412,000,000 JPY
19,404,000,000 JPY
19,317,000,000 JPY
Income taxes - current
490,000,000 JPY
525,000,000 JPY
5,549,000,000 JPY
5,531,000,000 JPY
Income taxes - deferred
1,099,000,000 JPY
1,099,000,000 JPY
-663,000,000 JPY
-661,000,000 JPY
Profit (loss)
3,687,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,687,000,000 JPY
3,787,000,000 JPY
14,446,000,000 JPY
14,446,000,000 JPY
14,446,000,000 JPY
14,517,000,000 JPY
14,446,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.